AUGX AUGMEDIX INC

Augmedix Launches New Service, Augmedix Prep, to Significantly Reduce Physician Chart Prep Burden

Augmedix Launches New Service, Augmedix Prep, to Significantly Reduce Physician Chart Prep Burden

Allows Physicians to Spend Less Time in the EHR and More Time with Patients

SAN FRANCISCO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- , Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation solutions, announces today the launch of Augmedix Prep, a new service that significantly reduces the burden on medical staff from preparing charts prior to a patient visit.

The new service features technology that prepares a patient note structure and content for the physician based on the unique visit type and the patient’s previous medical records. Alleviating this manual task ahead of time, physicians simply review the information prior to seeing the patient, allowing them to enter the visit ready to engage with the patient.

“Augmedix is on a mission to remove the barriers to care that frustrate both physicians and patients,” said Manny Krakaris, Chief Executive Officer of Augmedix. “Augmedix Prep is a significant value-add service that reduces the administrative burden exacerbating clinician burnout.”

Augmedix Prep is designed to address some of the most significant issues facing healthcare providers today, including reducing their workload, which can help mitigate clinician burnout and improve satisfaction, as well as allowing time back to focus on patients.

Augmedix Prep captures valuable information such as patient demographics, medication changes, up-to-date medical history, imaging, labs and diagnostic results, immunization history and past medical, family, and social history.

At its core, chart prep is a time-consuming administrative task that can negatively impact the patient encounter. Augmedix believes that by completing charting work prior to patient encounters, the physician will be better prepared and will offer more time in their schedule for delivering care, resulting in improved patient and provider experience and increasing patient satisfaction.

About Augmedix

Augmedix, Inc. (Nasdaq: AUGX) provides automated medical documentation and data services to large healthcare systems and physician practices, supporting medical offices, clinics, hospitals, emergency departments, and telemedicine nationwide. The company’s Ambient Automation Platform converts the natural conversation between physicians and patients into timely and comprehensive medical notes and performs a suite of related data services. These services relieve physicians of administrative burdens to enable more time for patient care. Augmedix’s proprietary platform uses automatic speech recognition, natural language processing and clinical datasets to capture the ambient visit conversation and generate a structured medical note. The structured medical note data is then used to deliver additional data services. Quality is assured by trained medical documentation specialists. To learn more about Augmedix, visit .

Forward-Looking Statements

This press release contains "forward-looking statements" that involve a number of risks and uncertainties. Such forward-looking statements include, without limitation, statements regarding the intended benefits of Augmedix Prep to healthcare providers. Actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to, risks detailed in our most recent Form 10-K filed with the U.S. Securities and Exchange Commission on March 30, 2022 as well as other documents that may be filed by us from time to time with the U.S. Securities and Exchange Commission. The forward-looking statements included in this press release represent our views as of the date of this press release. We undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.

Investors:

Caroline Paul

Gilmartin Group

Media:

Kaila Grafeman

Augmedix



EN
06/09/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on AUGMEDIX INC

 PRESS RELEASE

Commure Completes Merger with Augmedix

Commure Completes Merger with Augmedix SAN FRANCISCO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Commure, a healthcare technology company, announced today that it has completed the acquisition of Augmedix. Augmedix will now operate as a wholly-owned subsidiary of Commure. The merger was previously announced on July 19, 2024, and was approved by Augmedix stockholders at Augmedix’s special meeting of stockholders held on September 27, 2024. With the completion of the acquisition, Augmedix stockholders are entitled to $2.35 in cash for each share of Augmedix common stock they owned immediately prior...

 PRESS RELEASE

Augmedix Delivers 27% Revenue Growth for Second Quarter of 2024

Augmedix Delivers 27% Revenue Growth for Second Quarter of 2024 SAN FRANCISCO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today reported financial results for the three months ended June 30, 2024. “We believe we are approaching the proposed combination with Commure, Inc. from a position of strength, with consistent double-digit revenue growth and improving gross margins,” commented Manny Krakaris, Augmedix CEO. “Together, we believe we will be well-positioned to continue to streamline the medical documentati...

 PRESS RELEASE

Augmedix to Announce Second Quarter 2024 Financial Results on August 1...

Augmedix to Announce Second Quarter 2024 Financial Results on August 12, 2024 SAN FRANCISCO, Aug. 06, 2024 (GLOBE NEWSWIRE) --  (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, announced today it anticipates releasing second quarter 2024 results after the market closes on Monday, August 12, 2024. On July 19, 2024, Augmedix announced that it entered into a definitive agreement to be acquired by Commure, Inc., a leading provider of technology to healthcare systems. Due to this pending acquisition, management is not hosting a quarterly conference call. A...

 PRESS RELEASE

Augmedix to Join Forces with Commure

Augmedix to Join Forces with Commure Combination to Strengthen Ability to Deliver Frontier Ambient AI Solutions; Augmedix Stockholders to Receive $2.35 Per Share in All-Cash Acquisition by Commure SAN FRANCISCO, July 19, 2024 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced that it has entered into a definitive agreement to be acquired by Commure, Inc., a leading provider of technology to healthcare systems, in an all-cash transaction that values Augmedix at approximately $139 million in equity value. ...

 PRESS RELEASE

Emergency Services Inc. Partners with Augmedix to Introduce Generative...

Emergency Services Inc. Partners with Augmedix to Introduce Generative AI Solution That Relieves Clinician Burnout in Emergency Departments Emergency Services Inc. introduces Augmedix Go ED to central Ohio emergency departments to automate medical documentation SAN FRANCISCO, June 20, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, announced today that , a physician-owned emergency medicine services group in Columbus, Ohio, is introducing Augmedix Go ED to physicians in the emergency department (ED) at the second-largest healthc...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch